Loading clinical trials...
Loading clinical trials...
This study will collect information from people with Progressive Familial Intrahepatic Cholestasis (PFIC) as they use odevixibat in their daily lives. Odevixibat is a medicine that helps people with P...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Ipsen
NCT07191704 · PFIC - Progressive Familial Intrahepatic Cholestasis
NCT07293897 · Alagille Syndrome (ALGS), Progressive Familial Intrahepatic Cholestasis (PFIC)
NCT06778174 · Progressive Familial Intrahepatic Cholestasis
NCT06781242 · Cholestatic Liver Disease, Intrahepatic Cholestasis, and more
NCT06777914 · Hepatobiliary Cancers, Progressive Familial Intrahepatic Cholestasis (PFIC), and more
Seoul National University Hospital
Seoul
Severance Hospital, Yonsei University Health System
Seoul
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions